Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer

被引:0
|
作者
Sun, Linlin [1 ]
Luan, Shihai [2 ,3 ,4 ]
Yu, Liheng [5 ]
Zhu, Huiyuan [1 ]
Dong, Haiyang [1 ]
Liu, Xuemei [1 ]
Tao, Guangyu [1 ]
He, Pengbo [6 ,7 ,8 ]
Li, Qiang [6 ,7 ,8 ]
Chen, Weiqiang [6 ,7 ,8 ,9 ]
Yu, Zekuan [5 ]
Yu, Hong [1 ]
Zhu, Li [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Dept Radiol, 241 Huaihai West Rd, Shanghai 200030, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China
[3] Fudan Univ, Inst Neurosurg, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Key Lab Brain Funct Restorat & Neural Reg, Shanghai, Peoples R China
[5] Fudan Univ, Acad Engn & Technol, Shanghai, Peoples R China
[6] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China
[7] Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Gansu, Peoples R China
[8] Key Lab Basic Res Heavy Ion Radiat Applicat Med, Lanzhou, Gansu, Peoples R China
[9] Univ Chinese Acad Sci, Inst Modern Phys, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Radiomics; brain metastases (BM); lung cancer; magnetic resonance imaging (MRI); machine learning (ML); TEXTURE ANALYSIS; HIGH-RESOLUTION; HIGH-FIELD; CONTRAST; EPIDEMIOLOGY; IMAGES;
D O I
10.21037/tcr-24-1147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The pathological sub-classification of lung cancer is crucial in diagnosis, treatment and prognosis for patients. Quick and timely identification of pathological subtypes from imaging examinations rather than histological tests could help guiding therapeutic strategies. The aim of the study is to construct a non-invasive radiomics-based model for predicting the subtypes of lung cancer on brain metastases (BMs) from multiple magnetic resonance imaging (MRI) sequences. Methods: One hundred and sixty-one patients of primary lung cancer with synchronous BMs [121 with adenocarcinoma (AD); 40 with small cell lung carcinoma (SCLC)] were enrolled in the study (129 and 32 in the training set and validation set). A total of 960 radiomics features were extracted from multiple MRI sequences [fluid attenuated inversion recovery (FLAIR), diffusion weighted imaging (DWI), contrast- enhanced T1 weighted imaging (CE-T1WI) and contrast-enhanced susceptibility weighted imaging (CESWI)] and four clinical features were recorded. Forty-one key features were selected by the least absolute shrinkage selection operator (LASSO). The machine learning (ML) models for predicting AD and SCLC with radiomics features alone and with radiomics features plus clinical features were constructed using classifiers of logistic regression (LR), random forest (RF), support vector machine (SVM) and extreme gradient boosting (XGBoost). The prediction performance of models was evaluated by accuracy (ACC), sensitivity (SEN), specificity (SPE), F1 score and area under the curves (AUC). Results: The AUCs of LR, RF, SVM and XGBoost models were 0.8177 vs. 0.7604, 0.8177 vs. 0.7839, 0.4792 vs. 0.8594 and 0.9062 vs. 0.8750, respectively, when using radiomics features alone and radiomics features plus clinical features. In the best-performing model using XGBoost, combination of conventional MRI sequences and CE-SWI had better sub-classification performance than conventional MRI sequences. Conclusions: Radiomics of BMs from multiple MRI sequences provides high discriminatory performance in predicting AD and SCLC using classifiers of LR, RF and XGBoost, and can serve as a potential useful tool to non-invasively distinguish pathological subtypes of lung cancer.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Predicting survival time of lung cancer patients using radiomic analysis
    Chaddad, Ahmad
    Desrosiers, Christian
    Toews, Matthew
    Abdulkarim, Bassam
    ONCOTARGET, 2017, 8 (61) : 104393 - 104407
  • [42] A MRI radiomic signature for predicting brachytherapy outcomes in locally advanced cervical cancer
    Reuze, S.
    Alexis, A.
    Chargari, C.
    Bockel, S.
    Berthelot, K.
    Escande, A.
    Dumas, I.
    Orlhac, F.
    Haie-Meder, C.
    Deutsch, E.
    Robert, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S36 - S36
  • [43] MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer
    Zhao, Shijun
    Hou, Donghui
    Zheng, Xiaomin
    Song, Wei
    Liu, Xiaoqing
    Wang, Sicong
    Zhou, Lina
    Tao, Xiuli
    Lv, Lv
    Sun, Qi
    Jin, Yujing
    Ding, Lieming
    Mao, Li
    Wu, Ning
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 368 - 380
  • [44] MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
    Wen, Lu
    Liu, Jun
    Hu, Pingsheng
    Bi, Feng
    Liu, Siye
    Jian, Lian
    Zhu, Suyu
    Nie, Shaolin
    Cao, Fang
    Lu, Qiang
    Yu, Xiaoping
    Liu, Ke
    ACADEMIC RADIOLOGY, 2023, 30 : S176 - S184
  • [45] Identifying Cross-Scale Associations between Radiomic and Pathomic Signatures of Non-Small Cell Lung Cancer Subtypes: Preliminary Results
    Alvarez-Jimenez, Charlems
    Sandino, Alvaro A.
    Prasanna, Prateek
    Gupta, Amit
    Viswanath, Satish E.
    Romero, Eduardo
    CANCERS, 2020, 12 (12) : 1 - 17
  • [46] The Impact of Brain Metastases and Their Treatment on Health Utility Scores in Molecular Subsets of Lung Cancer Patients
    O'Kane, Grainne
    Labbe, Catherine
    Su, Susie
    Tse, Brandon
    Tam, Vivian
    Tse, Tiffany
    Doherty, Mark
    Stewart, Erin
    Brown, Catherine
    Cosio, Andrea Perez
    Patel, Devalben
    Liang, Mindy
    Gill, Gurshuran
    Rett, Alexandra
    Leung, Yvonne
    Naik, Hilten
    Eng, Lawson
    Mittmann, Nicole
    Leighl, Natasha
    Feld, Ronald
    Bradbury, Penelope
    Shepherd, Frances
    Xu, Wei
    Howell, Doris
    Liu, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S937 - S937
  • [47] Predicting pathological response in rectal cancer patients: a "PET Radiomic" approach with independent validation
    Leijenaar, R. T. H.
    Carvalho, S.
    Buijsen, J.
    Van Stiphout, R. G.
    Valentini, V.
    Dekker, A.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S9 - S10
  • [48] MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Bhatia, Ankush
    Birger, Maxwell
    Veeraraghavan, Harini
    Um, Hyemin
    Tixier, Florent
    McKenney, Anna Sophia
    Cugliari, Marina
    Caviasco, Annalise
    Bialczak, Angelica
    Malani, Rachna
    Flynn, Jessica
    Zhang, Zhigang
    Yang, T. Jonathan
    Santomasso, Bianca D.
    Shoushtari, Alexander N.
    Young, Robert J.
    NEURO-ONCOLOGY, 2019, 21 (12) : 1578 - 1586
  • [49] Utility of Short Initial MRI Brain in Brain Metastases Patients Treated With Stereotactic Radiosurgery
    Lin, T. A.
    Siu, C.
    Redmond, K. J.
    Bettegowda, C.
    Jackson, C.
    Lim, M.
    Kleinberg, L. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E573 - E573
  • [50] Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer
    Fan, Ming
    Zhang, Peng
    Wang, Yue
    Peng, Weijun
    Wang, Shiwei
    Gao, Xin
    Xu, Maosheng
    Li, Lihua
    EUROPEAN RADIOLOGY, 2019, 29 (08) : 4456 - 4467